ReNeuron Group plc (LON:RENE) Insider Buys £4,709.88 in Stock

ReNeuron Group plc (LON:RENE – Get Free Report) insider John Hawkins acquired 52,332 shares of the firm’s stock in a transaction dated Wednesday, July 12th. The stock was bought at an average price of GBX 9 ($0.12) per share, for a total transaction of £4,709.88 ($6,059.28).

ReNeuron Group Stock Up 2.8 %

Shares of LON RENE opened at GBX 9.20 ($0.12) on Thursday. ReNeuron Group plc has a 52-week low of GBX 5 ($0.06) and a 52-week high of GBX 33 ($0.42). The business’s 50 day moving average is GBX 7.85 and its two-hundred day moving average is GBX 9.01. The firm has a market cap of £5.26 million, a price-to-earnings ratio of -102.22 and a beta of 1.08. The company has a quick ratio of 2.02, a current ratio of 2.05 and a debt-to-equity ratio of 8.33.

Get ReNeuron Group alerts:

About ReNeuron Group

(Get Free Report)

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.

Recommended Stories

• Five stocks we like better than ReNeuron Group
• Contrarian Play: Beyond Meat Is At An Inflection Point 
• Alibaba Just Flashed Green, Very Green
• This Small Cap Stock Surged Over 100%
• The CPI Data Isn’t As Good As You Think It Is 
• How to Invest in Gold and Silver

Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.